Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

NCT01857843 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DEVICE: Zotalolimus Eluting Stent
DEVICE: Everolimus eluting stent
DRUG: Ezetimibe 10mg & Simvastatin 40mg
DRUG: Pravastatin 20mg

Sponsor

Yonsei University